NIH-funded research NIH-funded research

University of Cape Town HIV and TB Clinical Trials Unit

Official title: HIV/AIDS Clinical Trials Units University of Cape Town CTU 2020 to 2027

Funded at University of Cape Town · NIH-11234234 · Data updated 2026-11-12

This program runs clinical trials of new and improved HIV and tuberculosis treatments and prevention methods for people living in and around Cape Town, South Africa.

More AIDS research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Cape Town
NIH-funded
Lab location1 site (Rondebosch, South Africa)
Project startApril 1, 2007
Project endNovember 30, 2027
Funding year2026
Award (this year)$2,748,593
NIH project number5UM1AI069519-20
Project IDNIH-11234234 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are people living with HIV or tuberculosis, or those at elevated risk of these infections in the Cape Town area who meet specific trial eligibility criteria.

Less likely to help

People who live far from Cape Town, who do not meet trial eligibility rules, or whose condition is unrelated to HIV/TB are unlikely to directly benefit from these specific trials.

What this research studies

You would be connecting with a clinical trials unit based at the Desmond Tutu HIV Centre that runs studies in communities around Cape Town where HIV and TB are common. The unit supports six local research sites and offers treatment and prevention trials for HIV, tuberculosis, and related sexually transmitted infections. Trials involve regular clinic visits, medical exams, and may include blood or other sample collection to track health and study how treatments work. Joining a trial could mean closer medical monitoring and access to new therapies under careful supervision.

Why it matters

Potential benefit: If successful, this work could bring better treatments and prevention options for people with HIV and tuberculosis in southern Africa and beyond.

How similar studies have gone: Many prior clinical trials in HIV and TB have led to effective medicines and prevention tools, and this program builds on that well-established track record.

Where this research is happening

  • University of Cape Town
    Rondebosch, South Africa
    Active

Researchers

  • Principal investigator: Bekker, Linda-Gail Gail — University of Cape Town
  • Study coordinator: Bekker, Linda-Gail Gail

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.